89821-77-2

Upstream product

• 85207-16-5 allyl 2,3-O-isopropylidene-α-D-mannopyranoside 
• 85207-15-4 allyl 2,3:4,6-di-O-isopropylidene-α-D-mannopyranoside 
• 100639-23-4 (3aS,4S,6R,7R,7aS)-4-Allyloxy-7-benzyloxy-2,2-dimethyl-6-trityloxymethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran 
• 100639-22-3 (3aS,4S,6R,7R,7aS)-4-Allyloxy-2,2-dimethyl-6-trityloxymethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-ol 
• 100662-33-7 Toluene-4-sulfonic acid (3aS,4S,6R,7R,7aS)-4-allyloxy-7-hydroxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-ylmethyl ester 
• 100639-24-5 allyl 4-O-benzyl-2,3-O-isopropylidene-α-D-mannopyranoside 
• 41308-76-3 allyl α-D-mannopyranoside 
• 100-39-0 benzyl bromide 
• 530-26-7 D-Mannose 
• 100639-26-7 Methanesulfonic acid (3aS,4S,6R,7R,7aS)-4-allyloxy-7-benzyloxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-ylmethyl ester 
• 100639-25-6 allyl 2,3-O-isopropylidene-α-D-rhamnopyranoside 
• 475672-25-4 allyl L-rhamnopyranoside 
• 64650-81-3 allyl α-L-rhamnopyranoside 
• 73-34-7 L-rhamnose 

Downstream Products

• 102717-49-7 allyl 4-O-benzyl-3-O-methyl-α-L-rhamnopyranoside 
• 100639-27-8 allyl 4-O-benzyl-α-D-rhamnopyranoside 
• 1072450-37-3 trichloroacetimidoyl 2,3,4-tri-O-benzyl-β-D-xylopyranosyl-(1->3)-2,4-di-O-benzyl-β-D-xylopyranosyl-(1->4)-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1072450-36-2 triisopropylsilyl 2,3,4-tri-O-benzyl-β-D-xylopyranosyl-(1->3)-2,4-di-O-benzyl-β-D-xylopyranosyl-(1->4)-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1026022-17-2 O-triisopropylsilyl {[5-O-benzyl-2,3-di-O-benzylidene-β-D-apiofuranosyl-(1->3)]-2,4-di-O-benzyl-β-D-xylopyranosyl-(1->4)}-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1026022-16-1 O-triisopropylsilyl {[2,3-di-O-acetyl-5-O-benzyl-β-D-apiofuranosyl-(1->3)]-2,4-di-O-benzyl-β-D-xylopyranosyl-(1->4)}-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1026022-15-0 O-triisopropylsilyl [2,4-di-O-benzyl-β-D-xylopyranosyl-(1->4)]-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1026022-05-8 O-triisopropylsilyl 4-O-benzyl-2,3-di-O-isopropylidene-α-L-rhamnopyranoside 
• 1091625-32-9 allyl (3,4-di-O-benzyl-α-L-rhamnopyranosyl)-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranoside 
• 1091625-15-8 (3,4-di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranosyl)-(1->3)-2-O-acetyl-4-O-benzyl-α/β-L-rhamnopyranose trichloroacetimidate 
• 1091625-22-7 allyl (3,4-di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranosyl)-(1->3)-2-O-acetyl-4-O-benzyl-α-L-rhamnopyranoside 
• 824939-35-7 3,4-di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranose 
• 1116654-52-4 3,4-di-O-benzyl-2-O-levulinoyl-β-L-rhamnopyranose 
• 824939-34-6 allyl 3,4-di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranoside 

Relevant academic research and scientific papers

Synthesis of the hyper-branched core tetrasaccharide motif of chloroviruses

Chemical synthesis of complex oligosaccharides, especially those possessing hyper-branched structures with one or multiple 1,2-cisglycosidic bonds, is a challenging task. Complementary reactivity of glycosyl donors and acceptors and proper tuning of the s

TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X

The present invention relates to compounds derived from sugars which reproduce the epitopes of Shigella flexneri serotypes 3a and X and to the use thereof for the preparation of vaccine compositions. More specifically, the subject matter of the present in

SYNTHETIC OLIGOSACCHARIDE GROUP A STREPTOCOCCUS

The present invention provides novel synthetic poly-L-rhamnose oligosaccharides, compositions containing the same, and methods of preventing Group A Streptococcus infections.

Studies on carbohydrates XVIII. Synthesis of tetrasaccharide corresponding to biological repeat units of Serratia marcescens O18 polysaccharide

The synthesis of a blocked tetrasaccharide portion of the biological repeat unit, [→2)L-Rhapα(1→2)L-Rhapα(1→2)L-Rhapα(1→6)D-GlcNAcpα(1→], of the Serratia marcescens O18 polysaccharide was described. The key intermediate compounds was 3,4-blocked -L-rhamno

SYNTHESIS OF NEOGLYCOPROTEINS AS ARTIFICIAL ANTIGENS

The synthesis of various allyl glycosides of L-rhamnose containing ether and/or ester substituents are reported.Ozonolysis of allyl glycosides followed by reductive amination with ε-amino groups of lysine residues in bovine serum albumin using sodium cyan

SYNTHESIS OF PROPYL 4-O-(3,6-DI-O-METHYL-β-D-GLUCOPYRANOSYL)-2,3-DI-O-METHYL-α-D-RHAMNOPYRANOSIDE

Partial hydrolysis of allyl 2,3:4,6-di-O-isopropylidene-α-D-mannopyranoside gave allyl 2,3-O-isopropylidene-α-D-mannopyranoside which was converted into allyl 2,3-O-isopropylidene-α-D-rhamnopyranoside by reduction of the 6-O-tosyl derivative with lithium